Xynomic Pharmaceuticals Stock

xynomicpharma.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $21.8MM

Xynomic Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing oncology drug candidates.

Register To Buy and Sell Shares

For more details on financing and valuation for Xynomic Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Xynomic Pharmaceuticals’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Xynomic Pharmaceuticals.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Yinglin Mark Xu
Co-Founder, Chief Executive Officer, President & Chairman
Chasey Zhang
Vice President, Global Strategic Sourcing
Jason Wu Ph.D
Co-Founder & Chief Operating Officer
Jinwei Kou
Interim Chief Accounting Officer
Yong Cui Ph.D
Vice President, CMC

Frequently Asked Questions About Xynomic Pharmaceuticals’ Stock

plusminus
Can you buy Xynomic Pharmaceuticals’ stock?
Xynomic Pharmaceuticals is not publicly traded on NYSE or NASDAQ in the U.S. To buy Xynomic Pharmaceuticals’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Xynomic Pharmaceuticals’ stock?
Yes, you can sell stock of a private company like Xynomic Pharmaceuticals. Forge can help you sell your Xynomic Pharmaceuticals stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Xynomic Pharmaceuticals’ stock price?
Xynomic Pharmaceuticals is a privately held company and therefore does not have a public stock price. However, you may access Xynomic Pharmaceuticals’ private market stock price with Forge Data.
plusminus
What is Xynomic Pharmaceuticals’ stock ticker symbol?
Xynomic Pharmaceuticals does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Xynomic Pharma Completes Series B Crossover Financing |FinSMEs
Xynomic Pharma, a Dover, DE- and Shanghai, China-based oncology drug development company, completed a Series B crossover financing of undisclosed amount.
Xynomic Pharma Completes Series B Crossover Financing, Starts Four Pivotal Trials in Renal Cell Carcinoma (RCC) and Lymphoma, and Opens a R&D Center
/PRNewswire/ -- Xynomic Pharma, a clinical stage US-China oncology drug development company, today announced that it has completed Series B Crossover...
Updated on: May 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.